How a Viral Protein Helps Herpes Simplex Virus Escape Immune Defense
Author Information
Author(s): Chris Boutell, Delphine Cuchet-Lourenço, Emilia Vanni, Anne Orr, Mandy Glass, Steven McFarlane, Roger D. Everett
Primary Institution: MRC-University of Glasgow Centre for Virus Research (CVR), Glasgow, Scotland, United Kingdom
Hypothesis
How does the viral ubiquitin ligase ICP0 counteract intrinsic antiviral defense during HSV-1 infection?
Conclusion
The study concludes that ICP0 has dual targeting mechanisms that help it degrade SUMO-modified proteins, thereby counteracting intrinsic antiviral resistance to HSV-1 infection.
Supporting Evidence
- ICP0 induces the degradation of SUMO-conjugated proteins during HSV-1 infection.
- Mutation of SUMO interaction motifs within ICP0 affects its ability to stimulate HSV-1 infection.
- The SUMO conjugation pathway plays an important role in mediating intrinsic antiviral resistance.
Takeaway
The herpes virus has a special protein that helps it fight off the body's defenses, allowing it to infect cells more easily.
Methodology
The study involved experiments on human diploid fibroblasts to analyze the role of ICP0 in degrading SUMO-conjugated proteins during HSV-1 infection.
Limitations
The study may not account for all cellular factors involved in the antiviral response, and the results are based on specific cell types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website